Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Sirnaomics Doses the First Patient in Phase I/II Clinical Study of RNAi Therapeutic STP705 for Treatment of Facial Squamous Cell Skin Cancer In Situ 2022-08-18 23:46
Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Provisional Approval in New Zealand for Adolescents Aged 12 Through 17 2022-08-18 21:06
CG Pharmaceuticals Announces First Patient Dosed in Phase 1b/2 Study Evaluating Ivaltinostat for the Treatment of Pancreatic Adenocarcinoma 2022-08-18 21:00
Case Report of Long Term Complete Response in Hepatocellular Carcinoma to CARsgen's GPC3 CAR T Cells (CT011) Published in Frontiers in Immunology 2022-08-18 20:50
Standigm names Carl Foster chief business officer to expand strategic partnerships for AI drug discovery 2022-08-18 20:30
Ybrain Receives Translational Research Award 2022 Neuroergonomics Conference & NYC Neuromodulation Conference 2022-08-18 20:00
GenFleet Receives FDA Approval for Phase II Study of RIPK1 Inhibitor (GFH312) 2022-08-18 19:00
Zylox-Tonbridge maintains strong revenue and gross profit growth, including gross margin improvement driven by its platform-based strategy in 1H22 2022-08-18 14:57
WuXi Biologics Reports Strong 2022 Interim Results 2022-08-17 21:32
Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Provisional Approval in New Zealand as a First and Second Booster for Adults 2022-08-17 20:00
Akso Health Group Receives Notice of Filing Delinquency From Nasdaq 2022-08-17 18:00
WuXi STA Breaks Ground for New Pharmaceutical Manufacturing Facility in Middletown, Delaware 2022-08-17 01:47
WeTrade Group Inc. Announces Strategic Cooperation with MobiLab Medical Innovatives Inc., globally launching an unparalleled and one-of-a-kind Monkeypox Virus testing kits with combined insurance coverage products 2022-08-16 20:42
STANDIGM WINS GOLD AND BRONZE STEVIE® AWARDS IN 2022 INTERNATIONAL BUSINESS AWARDS® 2022-08-16 20:30
Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2022 2022-08-16 20:00
J INTS BIO, Oral presentation of Preclinical results of its Novel Oral 4th Generation EGFR TKI 'JIN-A02' at the 2022 World Conference on Lung Cancer in Vienna, Austria (IASLC 2022 WCLC) 2022-08-16 13:35
Bridge Biotherapeutics Receives FDA Authorization to Proceed with Phase 2 Study of BBT-877 2022-08-16 08:17
Lunit Announces Financial Results for the First Half of 2022 2022-08-12 21:00
WeTrade Group Inc. Announces US$50 Million Sales of Monkeypox Virus Test Kits to Parkway Medical Limited 2022-08-12 18:34
JIN-A02, A Novel 4th Generation EGFR TKI selected for the European Thoracic Oncology Platform - A First for Korean Pharma. 2022-08-12 10:13
1 116 117 118 119 120 432